Fresenius SE & Co. (OTCMKTS:FSNUY) Short Interest Update

Fresenius SE & Co. (OTCMKTS:FSNUY) was the recipient of a large drop in short interest during the month of May. As of May 15th, there was short interest totaling 49,381 shares, a drop of 65.8% from the April 30th total of 144,231 shares. Based on an average daily trading volume, of 338,840 shares, the short-interest ratio is currently 0.1 days. Approximately 0.0% of the shares of the company are sold short.

Fresenius SE & Co. Price Performance

Shares of OTCMKTS FSNUY opened at $10.64 on Friday. The firm has a market capitalization of $23.97 billion, a P/E ratio of 14.19 and a beta of 0.68. Fresenius SE & Co. has a one year low of $10.60 and a one year high of $33.93. The company’s fifty day moving average is $12.23 and its two-hundred day moving average is $13.57. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.00 and a current ratio of 1.32.

Fresenius SE & Co. (OTCMKTS:FSNUY) last issued its earnings results on Wednesday, May 6th. The company reported $0.24 EPS for the quarter, missing the consensus estimate of $0.25 by ($0.01). The company had revenue of $6.75 billion for the quarter, compared to analysts’ expectations of $6.79 billion. Fresenius SE & Co. had a return on equity of 10.29% and a net margin of 6.55%. Analysts forecast that Fresenius SE & Co. will post 1.05 EPS for the current fiscal year.

Analyst Ratings Changes

A number of research firms recently weighed in on FSNUY. Morgan Stanley reiterated an “overweight” rating on shares of Fresenius SE & Co. in a research report on Monday, April 20th. Citigroup restated a “buy” rating on shares of Fresenius SE & Co. in a research report on Tuesday, February 3rd. Three investment analysts have rated the stock with a Buy rating, According to MarketBeat, the stock has a consensus rating of “Buy”.

Fresenius SE & Co. Company Profile

Fresenius SE & Co KGaA is a global healthcare group headquartered in Bad Homburg vor der Höhe, Germany. Founded in 1912 by Eduard Fresenius, the company has grown into one of the world’s leading providers of products and services for dialysis, hospitals and outpatient medical care. Trading on major European exchanges and available over the counter in the U.S. as FSNUY, Fresenius SE & Co brings together a portfolio of specialized healthcare businesses under one corporate umbrella.

The company operates through four main business segments.